Cargando…
A fatal case of hepatitis B virus (HBV) reactivation during long-term, very-low-dose steroid treatment in an inactive HBV carrier
Hepatitis B virus (HBV) may be reactivated after chemotherapy or immunosuppressive therapy, and therefore administration of antiviral agents before such treatment is recommended. Most reported cases of reactivation are associated with high doses of immunosuppressive agents or combination therapy. We...
Autores principales: | Bae, Joong Ho, Sohn, Joo Hyun, Lee, Hye Soon, Park, Hye Sun, Hyun, Yil Sik, Kim, Tae Yeob, Eun, Chang Soo, Jeon, Yong Cheol, Han, Dong Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415881/ https://www.ncbi.nlm.nih.gov/pubmed/22893874 http://dx.doi.org/10.3350/cmh.2012.18.2.225 |
Ejemplares similares
-
Idiopathic portal hypertension in an "inactive" HBV carrier: a case report
por: Vassiliadis, Themistoklis G, et al.
Publicado: (2008) -
The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers
por: Kim, Eun Sun, et al.
Publicado: (2011) -
Prognostic Values of Fluctuations in Serum Levels of Alanine Transaminase in Inactive Carrier State of HBV Infection
por: Farzi, Hossein, et al.
Publicado: (2014) -
Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy
por: Delle Monache, Marco, et al.
Publicado: (2021) -
Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers
por: Ijaz, Bushra, et al.
Publicado: (2011)